A- A A+

"Good luck, social distance": rapid decarceration and community care for serious mental illness and substance use disorder during the COVID-19 pandemic. 

James JE, Dauria EF, Desai R, Bell A, Izenberg JM. 

Health Justice. 2023 Sep 18;11(1):39. doi: 10.1186/s40352-023-00238-5. PMID: 37721650; PMCID: PMC10506186.


Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020 [Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020]. 

Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J. 

Therapie. 2023 Jun 15:S0040-5957(23)00084-7. French. doi: 10.1016/j.therap.2023.06.004. Epub ahead of print. PMID: 37391322; PMCID: PMC10266982.


Trends in Opioid Toxicity-Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021. 

Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN. 

JAMA Netw Open. 2023 Jul 3;6(7):e2322303. doi: 10.1001/jamanetworkopen.2023.22303. PMID: 37418260; PMCID: PMC10329206.


Substance use disorders and COVID-19: reflections on international research and practice changes during the "poly-crisis".

Carver H, Ciolompea T, Conway A, Kilian C, McDonald R, Meksi A, Wojnar M. 

Front Public Health. 2023 Jul 17;11:1201967. doi: 10.3389/fpubh.2023.1201967. PMID: 37529435; PMCID: PMC10390069.


An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program. 

Yao X, McFaull SR, Champagne AS, Thompson W. 

BMC Public Health. 2023 Aug 4;23(1):1483. doi: 10.1186/s12889-023-16414-z. PMID: 37537534; PMCID: PMC10401736.


The Fentanyl System Shock - Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on "The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic". 

Meyer M, Westenberg JN, Krausz RM. 

Int J Health Policy Manag. 2023;12:7409. doi: 10.34172/ijhpm.2023.7409. Epub 2023 Mar 5. PMID: 37579419; PMCID: PMC10461848.


Trends in Substance Use and Abuse During COVID-19 Among the General Population. 

Shankar R, Bhattacharya V. 

Addict Health. 2022 Oct;14(4):296-308. doi: 10.34172/ahj.2022.1274. Epub 2022 Oct 29. PMID: 37559794; PMCID: PMC10408753.


Estimating the uncertain effect of the COVID pandemic on drug overdoses. 

Moghtaderi A, Zocchi MS, Pines JM, Venkat A, Black B (2023) 

PLoS ONE 18(8): e0281227. doi.org/10.1371/journal.pone.0281227


Chronic opioid use and mortality outcomes in patients admitted with COVID-19: A retrospective cohort study. 

Patel A, Kim J, Brown D, Lin HM, Ouyang Y, Shekane P. 

J Opioid Manag. 2023 Jul-Aug;19(4):321-327. doi: 10.5055/jom.2023.0789. PMID: 37644790.



Strengthening the social resilience of people living at the intersection of precariousness and migration during pandemics: action recommendations developed in Munich, Germany. 

Öcek ZA, Geise M, Volkmann AM, Basili A, Klünder V, Coenen M. 

Front Public Health. 2023 Aug 2;11:1201215. doi: 10.3389/fpubh.2023.1201215. PMID: 37601211; PMCID: PMC10433162.


Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications

Hannah Thurgur,  Anne Katrin Schlag,  Elizabeth Iveson,  Adele Hosseini,  Michael Lynskey,  David J. Nutt

Drug Science, UK, August 31 2023


COVID-19 impact on opioid overdose after jail release in Massachusetts. 

Friedmann PD, Dunn D, Michener P, Bernson D, Stopka TJ, Pivovarova E, Ferguson WJ, Rottapel R, Hoskinson R Jr, Wilson D, Evans EA. 

Drug Alcohol Depend Rep. 2023 Mar;6:100141. doi: 10.1016/j.dadr.2023.100141. Epub 2023 Feb 27. PMID: 36879616; PMCID: PMC9968665.


Effects on Neonatal Abstinence Syndrome of Parental Caregivers' Ability to Leave the Postpartum Unit During the COVID-19 Pandemic. 

Cooney T, Cote U, Bergen E, Dampier A, Inkila L, Edwards C. 

Nurs Womens Health. 2023 Aug;27(4):283-290. doi: 10.1016/j.nwh.2023.02.004. Epub 2023 Jun 1. PMID: 37269876; PMCID: PMC10232939.


Changes in the alcohol-specific disease burden during the COVID-19 pandemic in Germany: interrupted time series analyses. 

Manthey J, Kilian C, Schäfer I, Wirth M, Schulte B. 

Eur J Public Health. 2023 Aug 1;33(4):645-652. doi: 10.1093/eurpub/ckad103. PMID: 37365723; PMCID: PMC10393477.


Substance use, psychiatric symptoms, personal mastery, and social support among COVID-19 long haulers: A compensatory model. 

Tam CC, Qiao S, Garrett C, Zhang R, Aghaei A, Aggarwal A, et al. (2023) 

PLoS ONE 18(8): e0289413. https://doi.org/10.1371/journal.pone.0289413


A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. 

Augusto, D.G., Murdolo, L.D., Chatzileontiadou, D.S.M. et al. 

Nature (2023). doi.org/10.1038/s41586-023-06331-x


Nur leicht COVID-krank oder Long-COVID – alles eine Frage der Gene: Eric Topol erklärt „bahnbrechenden“ Nature-Artikel

Medscape - 21. Jul 2023.


Predictors of General Deviance in the Context of COVID-19. 

Paat YF, Hope TL, Zamora H Jr, Hernandez E. 

Int J Offender Ther Comp Criminol. 2023 Jul 2:306624X231172644. doi: 10.1177/0306624X231172644. Epub ahead of print. PMID: 37394821; PMCID: PMC10315875.


Trends in Opioid Toxicity-Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021. 

Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN. 

JAMA Netw Open. 2023 Jul 3;6(7):e2322303. doi: 10.1001/jamanetworkopen.2023.22303. PMID: 37418260; PMCID: PMC10329206.


Opioid use in the era of COVID-19: a multifaceted study of the opioid epidemic in Canada. 

Hutchinson M, Lavigne É, Patterson Z. 

Front Pharmacol. 2023 May 25;14:1122441. doi: 10.3389/fphar.2023.1122441. PMID: 37305538; PMCID: PMC10247957.


Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019-2021. 

den Boogert EM, Veldhuijzen IK, Generaal E, Prins M, Sonneveld MJ, van der Meer AJ, Zantkuijl P, van Benthem BHB, de Coul ELMO. 

BMC Public Health. 2023 Jun 27;23(1):1244. doi: 10.1186/s12889-023-16143-3. PMID: 37370036; PMCID: PMC10294379.


Mental health in Europe during the COVID-19 pandemic: a systematic review

Ahmed, Nafiso et al.

The Lancet Psychiatry, Volume 10, Issue 7, 537 - 556 


Impact of COVID-19 on the lives of people with severe mental illness-front-line community psychiatry workers observation from a provincial survey of assertive community treatment teams in Ontario, Canada. 

Kassam A, Beder M, Sediqzadah S, Levy M, Ritts M, Maher J, Kirwan N, Law S. 

Int J Ment Health Syst. 2023 Jun 16;17(1):18. doi: 10.1186/s13033-023-00585-8. PMID: 37328776; PMCID: PMC10273506.


Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors. 

Jarlais DD, Weng CA, Feelemyer J, McKnight C. 

Drug Alcohol Depend Rep. 2023 Sep;8:100171. doi: 10.1016/j.dadr.2023.100171. Epub 2023 Jun 8. PMID: 37323939; PMCID: PMC10247299.


General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. 

Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. 

Int J Drug Policy. 2023 Jun 8;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub ahead of print. PMID: 37336071; PMCID: PMC10247883.


Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis. 

Fico G, Oliva V, De Prisco M, Fortea L, Fortea A, Giménez-Palomo A, Anmella G, Hidalgo-Mazzei D, Vazquez M, Gomez-Ramiro M, Carreras B, Murru A, Radua J, Mortier P, Vilagut G, Amigo F, Ferrer M, García-Mieres H, Vieta E, Alonso J. 

J Affect Disord. 2023 Jun 17:S0165-0327(23)00799-1. doi: 10.1016/j.jad.2023.06.034. Epub ahead of print. PMID: 37336249; PMCID: PMC10276655.


No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users. 

Rydberg A, Dodoo CA, Schneekloth TD, Abulseoud OA. 

J Cannabis Res. 2023 Jun 19;5(1):23. doi: 10.1186/s42238-023-00193-w. PMID: 37337275; PMCID: PMC10280862.


Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic. 

Bowles JM, Kolla G, Smith LR, Scheim A, Dodd Z, Werb D. 

Drug Alcohol Depend Rep. 2023 Jun;7:100167. doi: 10.1016/j.dadr.2023.100167. Epub 2023 May 20. PMID: 37273749; PMCID: PMC10199487.


Was retrospective change measurement conducted with Covid-19 containment inconsistent? Comparing prospective and retrospective change measures using data from a national survey on substance use and addictive behaviors. 

Dupuis M, Studer J, Wicki M, Marmet S, Gmel G. 

PLoS One. 2023 Jun 2;18(6):e0286597. doi: 10.1371/journal.pone.0286597. PMID: 37267260; PMCID: PMC10237494.


Hospital Use and Mortality Among Decarcerated Individuals With Substance Use Disorder After a Large-scale COVID-19 Emergency Prison Release Program. 

Treitler P, Nowels M, Feder KA, Saloner B, Reeves R, DeBilio L, Crystal S. 

JAMA Health Forum. 2023 Jun 2;4(6):e231200. doi: 10.1001/jamahealthforum.2023.1200. PMID: 37266961; PMCID: PMC10238949.